Anavex Life Sciences Corp. (AVXL)
NASDAQ·Healthcare·Biotechnology
$1.28
-2.67%
Mkt Cap $126.07M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$11.00
Range $11.00 – $11.00
Implied Upside
+762.7%
Consensus $11.00 vs current $1.28
NASDAQ·Healthcare·Biotechnology
$1.28
-2.67%
Mkt Cap $126.07M
No recent rating data.
Price Target (1 analysts)
$11.00
Range $11.00 – $11.00
+762.7%
Consensus $11.00 vs current $1.28